tiprankstipranks
Nexalin Technology, Inc. (NXL)
NASDAQ:NXL
US Market

Nexalin Technology, Inc. (NXL) Stock Price & Analysis

34 Followers

NXL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.25 - $3.40
Previous Close$1.43
Volume274.88K
Average Volume (3M)807.47K
Market Cap
$10.93M
Enterprise Value$6.77M
Total Cash (Recent Filing)$4.70M
Total Debt (Recent Filing)$530.49K
Price to Earnings (P/E)-2.3
Beta1.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding7,436,562
10 Day Avg. Volume383,990
30 Day Avg. Volume807,473
Standard Deviation0.89
R-Squared0.10
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.46
Price to Sales (P/S)8.27
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.07
Enterprise Value/Gross Profit7.06
Enterprise Value/Ebitda-254.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

20.51%0.52%0.00%78.97%
20.51%
Insiders
0.00% Other Institutional Investors
78.97% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NXL FAQ

What was Nexalin Technology, Inc.’s price range in the past 12 months?
Nexalin Technology, Inc. lowest stock price was $0.25 and its highest was $3.40 in the past 12 months.
    What is Nexalin Technology, Inc.’s market cap?
    Currently, no data Available
    When is Nexalin Technology, Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Nexalin Technology, Inc.’s earnings last quarter?
    Currently, no data Available
    Is Nexalin Technology, Inc. overvalued?
    According to Wall Street analysts Nexalin Technology, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Nexalin Technology, Inc. pay dividends?
      Nexalin Technology, Inc. does not currently pay dividends.
      What is Nexalin Technology, Inc.’s EPS estimate?
      Nexalin Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Nexalin Technology, Inc. have?
      Nexalin Technology, Inc. has 7,436,562 shares outstanding.
        What happened to Nexalin Technology, Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Nexalin Technology, Inc.?
        Currently, no hedge funds are holding shares in NXL
        ---

        Nexalin Technology, Inc. Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Positive
        20 days / 200 days
        Momentum
        67.08%
        12-Months-Change

        Fundamentals

        Return on Equity
        -107.05%
        Trailing 12-Months
        Asset Growth
        -51.13%
        Trailing 12-Months

        Company Description

        Nexalin Technology, Inc.

        Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Novartis
        Align Tech
        Thermo Fisher
        Illumina
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis